Structure (Dexlansoprazole Delayed Release Capsules 1)
Dexlansoprazole Capsule, Delayed Release
Product Images NDC 49884-147
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 49884-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Dexlansoprazole Delayed Release Capsules 2)
The graph shows plasma concentration levels (in ng/mL) for dexlansoprazole doses of 30 mg and 60 mg over time. The x-axis is not readable, and the y-axis shows concentrations ranging from 0 to 1200 ng/mL.*
Bottle Of 30s (60 mg)
This is a description of Dexlansoprazole Delayed-Release Capsules, NDC 49884-148-11, containing 60 mg of Dexlansoprazole as enteric-coated granules. The usual dosage should be checked from the accompanying prescribing information. The product contains FD&C Yellow No.5 (tartrazine) which may cause allergic reactions in certain individuals. It should not be accepted if the seal over the bottle opening is broken or missing. The storage temperature recommended is 20° to 25°C (68° to 77°F); excursions are permitted to 15° to 30°C (59° to 86°F), and it needs to be kept out of reach of children. The pharmacy should provide the medication guide to each patient. It is distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977 USA and manufactured by Par Formulations Private Limited in India with Mfg. Lic. No.TNO0002121. The lot number is LA148-11-74-01 dated 12/20.*
Bottle Of 90s (60 mg)
NDC 49884-148-09 Dexlansoprazole Delayed-Release Capsules 60 mg - Medication Guide available on www.parpharm.com. Each capsule contains 60 mg of Dexlansoprazole as enteric-coated granules. This drug has FD&C Yellow No. 5 (tartrazine) which may cause allergic reactions in susceptible individuals. It is important to keep this drug out of reach of children and store at a temperature range of 20° to 25°C (68° to 77°F). Made in India and distributed by Par Pharmaceutical.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
